Arax Advisory Partners’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
Arax Advisory Partners's TNDM Position: Q3 2026 in Review
Arax Advisory Partners reduced its Tandem Diabetes Care (TNDM) stake by 21% in Q3 2026, selling an estimated $23.2K and leaving 4,759 shares worth $77.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3005.
Arax Advisory Partners first reported a position in TNDM in Q2 2024 and has held it in 10 quarters since. The position peaked at $90.5K in Q2 2026. 267 funds tracked by Wall St. Rank hold TNDM as of Q3 2026.
- Arax Advisory Partners held 4,759 shares of Tandem Diabetes Care worth $77.6K as of Q3 2026.
- Arax Advisory Partners sold 1,237 Tandem Diabetes Care shares in Q3 2026, an estimated $23.2K.
- Tandem Diabetes Care made up ﹤0.01% of Arax Advisory Partners's portfolio in Q3 2026, its #3005 holding.
- Arax Advisory Partners first reported a position in Tandem Diabetes Care in Q2 2024 and has held it in 10 quarters since.
- Arax Advisory Partners's Tandem Diabetes Care position peaked at $90.5K in Q2 2026.
- 267 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2026.
Based on Arax Advisory Partners's 13F filing for Q3 2026, filed 12 Nov 2026.